BioCentury
ARTICLE | Clinical News

HemoCue Albumin 201 regulatory update

June 23, 2008 7:00 AM UTC

FDA granted CLIA waiver to Quest Diagnostics’ HemoCue AB subsidiary for HemoCue Albumin 201 for monitoring microalbuminuria. The quantitative point-of-case test measures levels of albumin, which can s...